Scherer T A, Spengler C M, Owassapian D, Imhof E, Boutellier U
Department of Internal Medicine, Triemli Hospital, Zurich, Switzerland.
Am J Respir Crit Care Med. 2000 Nov;162(5):1709-14. doi: 10.1164/ajrccm.162.5.9912026.
Inspiratory muscle training may have beneficial effects in certain patients with chronic obstructive pulmonary disease (COPD). Because of the lack of a home training device, normocapnic hyperpnea has rarely been used as a training mode for patients with COPD, and is generally considered unsuitable to large-scale application. To study the effects of hyperpnea training, we randomized 30 patients with COPD and ventilatory limitation to respiratory muscle training (RMT; n = 15) with a new portable device or to breathing exercises with an incentive spirometer (controls; n = 15). Both groups trained twice daily for 15 min for 5 d per week for 8 wk. Training-induced changes were significantly greater in the RMT than in the control group for the following variables: respiratory muscle endurance measured through sustained ventilation (+825 +/- 170 s [mean +/- SEM] versus -27 +/- 61 s, p < 0.001), inspiratory muscle endurance measured through incremental inspiratory threshold loading (+58 +/- 10 g versus +21.7 +/- 9.5 g, p = 0.016), maximal expiratory pressure (+20 +/- 7 cm H(2)O versus -6 +/- 6 cm H(2)O, p = 0.009), 6-min walking distance (+58 +/- 11 m versus +11 +/- 11 m, p = 0.002), V O(2peak) (+2.5 +/- 0.6 ml/kg/min versus -0.3 +/- 0.9 ml/kg/min, p = 0.015), and the SF-12 physical component score (+9.9 +/- 2.7 versus +1.8 +/- 2.4, p = 0.03). Changes in dyspnea, maximal inspiratory pressure, treadmill endurance, and the SF-12 mental component score did not differ significantly between the RMT and control groups. In conclusion, home-based respiratory muscle endurance training with the new device used in this study is feasible and has beneficial effects in subjects with COPD and ventilatory limitation.
吸气肌训练可能对某些慢性阻塞性肺疾病(COPD)患者有有益影响。由于缺乏家庭训练设备,常氧高通气很少被用作COPD患者的训练模式,并且一般认为不适用于大规模应用。为研究高通气训练的效果,我们将30例有通气受限的COPD患者随机分为两组,一组使用新型便携式设备进行呼吸肌训练(RMT;n = 15),另一组使用激励肺量计进行呼吸锻炼(对照组;n = 15)。两组均每天训练2次,每次15分钟,每周训练5天,共训练8周。对于以下变量,RMT组训练引起的变化显著大于对照组:通过持续通气测量的呼吸肌耐力(+825±170秒[平均值±标准误] 对比 -27±61秒,p < 0.001)、通过递增吸气阈值负荷测量的吸气肌耐力(+58±10克对比 +21.7±9.5克,p = 0.016)、最大呼气压力(+20±7厘米水柱对比 -6±6厘米水柱,p = 0.009)、6分钟步行距离(+58±11米对比 +11±11米,p = 0.002)、峰值摄氧量(+2.5±0.6毫升/千克/分钟对比 -0.3±0.9毫升/千克/分钟,p = 0.015)以及SF-12身体成分评分(+9.9±2.7对比 +1.8±2.4,p = 0.03)。RMT组和对照组在呼吸困难、最大吸气压力、跑步机耐力以及SF-12心理成分评分方面的变化无显著差异。总之,本研究中使用的新型设备进行家庭呼吸肌耐力训练对有通气受限的COPD患者是可行的且有有益作用。